Trial Profile
Evaluation of pre-dose and post-dose anti-factor Xa levels with enoxaparin use during pregnancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- 14 Jan 2008 Planned patients number changed from 20 to 15 as reported by ClinicalTrials.gov.
- 14 Jan 2008 Status changed from recruiting to completed.
- 09 Nov 2006 New trial record.